Please provide your email address to receive an email when new articles are posted on . Among patients with breast cancer in China, those who underwent adjuvant endocrine therapy had more prevalent ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...

Despite the availability of effective prescription therapies for menopausal symptoms, many women delayed seeking treatment, often using nonprescription options instead or no treatment at all, ...

About two thirds of breast cancers are classified as “hormone receptor positive” disease. These cancer cells express a group of proteins that bind to hormones, including estrogen and progesterone, ...

The association of a treatment-related adverse effect with treatment success has been reported in various clinical situations. The development of vasomotor or joint symptoms is an indication of ...

Incidence and predictors of ovarian function recovery (OFR) in exemestane patients with breast cancer (BC) with chemotherapy-induced amenorrhea (CIA) using two estradiol assays. Background: ...

Significant improvement seen in endocrine symptom subscale score, hot flash score, FACT-Breast total score. HealthDay News — A 10-week acupuncture intervention significant reduces endocrine symptoms ...

Prostate cancer remains one of the most common cancers worldwide, with an estimated 1.4 million new cases and nearly 400,000 deaths in 2022, as noted by Lin and colleagues in their study published in ...

In women with breast cancer vasomotor and joint symptoms are common adverse effects of endocrine treatment. Some studies have indicated that the development of vasomotor symptoms is associated with ...

This is a young woman with node-positive breast cancer. Currently, she is receiving combined endocrine therapy with tamoxifen and a gonadotropin-releasing hormone (GnRH)-agonist, goserelin, to ...

The is a summary of a study published as a preprint on ResearchSquare.com. It has not yet been peer reviewed. Adjuvant endocrine therapies for hormone receptor-positive (HR+) breast cancer, including ...

Effects of lumpectomy or mastectomy on plasma epoxyeicosatrienoic acid levels in patients with estrogen receptor positive, HER2-negative breast cancer. Study of the impact of Charlson comorbidity ...